# Ubiquinol Kaneka QH (Coenzyme Q10)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/ubiquinol-kaneka-qh
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-04
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Ubiquinol-10, Reduced Coenzyme Q10, Active CoQ10, QH, Kaneka QH, 2,3-dimethoxy-5-methyl-6-(10-hydroxydecaprenyl)-1,4-benzoquinol, CoQ10H2, Reduced ubiquinone, Active ubiquinone

## Overview

Ubiquinol Kaneka QH is the reduced, active [antioxidant](/ingredients/condition/antioxidant) form of Coenzyme Q10 (CoQ10), produced by Japanese manufacturer Kaneka Corporation. It supports [mitochondrial](/ingredients/condition/energy) ATP synthesis by serving as a critical electron carrier in the electron transport chain, with research showing significantly superior bioavailability compared to standard oxidized ubiquinone CoQ10.

## Health Benefits

• Increases ubiquinol blood levels ~8x when taking 200mg daily for at least 30 days (limited evidence quality - no study design details provided)
• Supports cellular [energy production](/ingredients/condition/energy) by enabling 95% of ATP synthesis through mitochondrial electron transport chain function (mechanistic evidence only)
• Acts as an antioxidant by scavenging free radicals and preventing [lipid peroxidation](/ingredients/condition/antioxidant) in membranes and LDL (mechanistic evidence only)
• Demonstrates 2x better absorption than conventional oxidized CoQ10 (general comparison claim without specific trial data)
• Shows 698% higher peak blood levels and 485% higher bioavailability when formulated with VESIsorb delivery system (pilot pharmacokinetic study, sample size unspecified)

## Mechanism of Action

Ubiquinol functions as a lipid-soluble electron carrier within the mitochondrial inner membrane, shuttling electrons between Complex I, Complex II, and Complex III of the electron transport chain to drive ATP synthase activity, which accounts for approximately 95% of cellular [ATP production](/ingredients/condition/energy). In its reduced (QH2) form, ubiquinol donates electrons to neutralize [reactive oxygen species](/ingredients/condition/antioxidant) including superoxide radicals and lipid peroxyl radicals, regenerating vitamin E (alpha-tocopherol) in the process. Unlike ubiquinone, ubiquinol does not require enzymatic reduction by NQO1 (NAD(P)H dehydrogenase) before becoming bioactive, explaining its markedly greater absorption and plasma concentration after oral dosing.

## Clinical Summary

A key pharmacokinetic finding shows that 200mg daily of Kaneka QH ubiquinol for at least 30 days increases plasma ubiquinol concentrations approximately 8-fold compared to baseline, though the specific study design details and sample sizes supporting this figure have not been fully disclosed, limiting confidence in the estimate. Comparative absorption studies suggest ubiquinol achieves meaningfully higher peak plasma concentrations than equivalent doses of ubiquinone CoQ10, particularly in older adults whose endogenous conversion capacity declines with age. Clinical trials examining CoQ10 in heart failure patients (notably the Q-SYMBIO trial with 420 participants) used ubiquinone rather than ubiquinol specifically, meaning direct large-scale [cardiovascular](/ingredients/condition/heart-health) outcome data for Kaneka QH remains limited. Overall, the evidence base for ubiquinol's mechanistic role in [ATP synthesis](/ingredients/condition/energy) is robust, but large randomized controlled trials using Kaneka QH specifically with clinical endpoints are still needed.

## Nutritional Profile

Ubiquinol Kaneka QH is a purified bioactive compound, not a whole food, so it contains no macronutrients (protein, carbohydrates, fat), fiber, or conventional micronutrients. The active ingredient is ubiquinol (the reduced, electron-rich form of Coenzyme Q10), a fat-soluble benzoquinone compound with a 10-unit isoprenoid side chain. Typical supplemental doses range from 100–200mg per serving. Kaneka QH is a proprietary, fermentation-derived form of ubiquinol (produced via yeast fermentation), distinguished from synthetic CoQ10 by being in the pre-reduced (active) state, which does not require enzymatic conversion in the body. Bioavailability is significantly enhanced compared to ubiquinone (oxidized CoQ10): clinical data indicate blood ubiquinol levels increase approximately 8-fold with 200mg daily over 30+ days. Being lipophilic, absorption is optimized when taken with dietary fat. Each molecule contains a redox-active quinone ring capable of donating and accepting electrons, which underpins both its role in the [mitochondrial](/ingredients/condition/energy) electron transport chain (Complexes I, II, and III) and its antioxidant capacity (scavenging [reactive oxygen species](/ingredients/condition/antioxidant) and protecting membrane phospholipids from lipid peroxidation). No vitamins, minerals, or dietary fiber are present in meaningful quantities.

## Dosage & Preparation

Clinically studied dose: 200mg daily of Kaneka Ubiquinol for at least 30 days to achieve ~8x increase in ubiquinol levels in healthy adults. Available as stabilized softgel or powder form (e.g., 100mg capsules) with pure reduced CoQ10. VESIsorb-formulated versions use equivalent dosing to plain ubiquinol but show enhanced absorption. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Ubiquinol is generally well tolerated at doses up to 300mg daily, with the most commonly reported side effects being mild gastrointestinal symptoms such as nausea, diarrhea, and stomach upset, particularly when taken without food. It may potentiate the effects of antihypertensive medications, leading to additive [blood pressure](/ingredients/condition/heart-health) lowering, and there is evidence it can reduce the anticoagulant efficacy of warfarin (vitamin K antagonist), requiring INR monitoring if combined. Individuals taking statins (HMG-CoA reductase inhibitors) should be aware that statins suppress endogenous CoQ10 synthesis, making supplementation potentially relevant, though ubiquinol does not interfere with statin pharmacokinetics. Safety data in pregnancy and lactation is insufficient to make a firm recommendation, and use should be discussed with a healthcare provider before supplementing during these periods.

## Scientific Research

The research dossier reveals a concerning lack of specific human RCTs, meta-analyses, or PubMed PMIDs for Ubiquinol Kaneka QH. While Kaneka's research shows 200mg daily increases ubiquinol levels ~8x in healthy adults, no study design details, sample sizes, or PMIDs are provided. A pharmacokinetic pilot crossover study compared plain QH Ubiquinol to VESIsorb formulations, but again lacked sample size information and PMID references.

## Historical & Cultural Context

No evidence of traditional use in historical medicine systems exists for ubiquinol. CoQ10/ubiquinol is a modern-discovered endogenous compound and supplement ingredient, not rooted in ancient practices like Ayurveda or Traditional Chinese Medicine.

## Synergistic Combinations

Vitamin E, omega-3 fatty acids, selenium, alpha-lipoic acid, magnesium

## Frequently Asked Questions

### What is the difference between ubiquinol and ubiquinone CoQ10?

Ubiquinol (CoQH2) is the fully reduced, electron-rich form of CoQ10 that is directly bioactive as both an antioxidant and mitochondrial electron carrier, while ubiquinone (CoQ10) is the oxidized form that must be enzymatically converted to ubiquinol by NQO1 reductase before performing these functions. Absorption studies show ubiquinol achieves significantly higher plasma concentrations per milligram consumed, making it particularly advantageous for older adults and individuals with metabolic conditions that impair the reduction step.

### How long does it take for Kaneka QH ubiquinol to raise CoQ10 blood levels?

Research on Kaneka QH indicates that at a dose of 200mg daily, measurable increases in plasma ubiquinol levels are observed within days, but maximum elevation of approximately 8-fold above baseline requires at least 30 days of consistent supplementation. This plateau likely reflects the time needed to saturate lipoproteins and tissue compartments, particularly LDL particles which are the primary CoQ10 transport vehicle in blood.

### Can ubiquinol help with heart failure?

CoQ10 supplementation has shown promise in heart failure patients, most notably in the Q-SYMBIO randomized controlled trial (420 participants, 2-year follow-up), where 300mg daily of CoQ10 reduced major adverse cardiovascular events and all-cause mortality compared to placebo. However, that landmark trial used ubiquinone rather than Kaneka QH ubiquinol specifically, so while the mechanistic rationale for ubiquinol's superior bioavailability is sound, dedicated large-scale trials using ubiquinol for heart failure endpoints are still lacking.

### Does ubiquinol interact with blood thinners like warfarin?

Yes, ubiquinol and CoQ10 in general have been reported to reduce the anticoagulant effectiveness of warfarin (Coumadin), potentially decreasing INR values and raising clotting risk in patients dependent on anticoagulation therapy. Anyone taking warfarin or other vitamin K antagonists should inform their physician before starting ubiquinol supplementation and have their INR monitored more frequently during the initial weeks of use.

### What is the best dose of ubiquinol for general health and energy?

For general cardiovascular and mitochondrial support, most clinical and pharmacokinetic research centers on doses of 100mg to 200mg of ubiquinol daily taken with a fat-containing meal to maximize lymphatic absorption. At 200mg daily of Kaneka QH specifically, plasma ubiquinol levels increase approximately 8-fold after 30 days, which represents a well-studied dose; doses above 300mg daily have not demonstrated proportionally greater benefit and are associated with a higher incidence of gastrointestinal side effects.

### Is Kaneka QH ubiquinol safe for children?

While ubiquinol is generally recognized as safe, there is limited clinical evidence specifically evaluating Kaneka QH ubiquinol in children, and pediatric dosing guidelines have not been established. Parents should consult with a pediatrician before giving this ingredient to children, as safety data in this population remains insufficient.

### How does Kaneka QH ubiquinol compare to CoQ10 supplements from other manufacturers?

Kaneka QH is the branded ubiquinol form produced through a proprietary fermentation process and demonstrates approximately 8-fold higher blood level increases compared to standard ubiquinone at 200mg daily. Other manufacturers may produce ubiquinol or ubiquinone with different bioavailability profiles, though direct head-to-head comparisons between brands are limited.

### What factors affect how well my body absorbs Kaneka QH ubiquinol?

Ubiquinol absorption is enhanced when taken with dietary fat, as it is fat-soluble, and consistent daily supplementation for at least 30 days is needed to achieve significant blood level increases. Age, metabolic health, and concurrent medications (particularly statin use, which depletes natural CoQ10) may influence individual absorption and retention rates.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*